Ulcerative Colitis Clinical Trials in Chicago

Showing 581-600 of 699 trials

Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome

NCT01609062

The primary objective of this study was to evaluate the safety of a 2.0 mg/kg/week and a 4.0 mg/kg/week of BMN 110 in patients with Morquio A syndrome for up to 196 weeks. Secondary objectives were to investigate the effect of the two doses on exercise capacity for up to 196 weeks. In addition, the pharmacokinetic (PK) parameters of both doses of BMN 110 was assessed.

Mucopolysaccharidosis IVAMorquio A SyndromeMPS IVA

BioMarin Pharmaceutical25 participantsStarted Apr 2012

Oakland, California, United States • Chicago, Illinois, United States • New York, New York, United States +8 more locations

COMPLETEDPhase 22.2 miles

Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

NCT00390234

This phase II trial is studying how well ziv-aflibercept works in treating patients with locally advanced, unresectable or metastatic gynecologic soft tissue sarcoma. Ziv-aflibercept may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.

Fallopian Tube CancerFemale Reproductive CancerOvarian Carcinosarcoma+9 more

National Cancer Institute (NCI)63 participantsStarted Sep 2006

Duarte, California, United States • Los Angeles, California, United States • Sacramento, California, United States +13 more locations

Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome

Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

Ulcerative Colitis Trials in Other Cities

Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)

Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Gadobutrol Enhanced MRA of the Renal Arteries

Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis

Tube Versus Trabeculectomy (TVT) Study

Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma

Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients

Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer

Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)

Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

Childhood Adenotonsillectomy Study for Children With OSAS

Combination of Orally Inhaled BI1744CL/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease ( COPD)

MANAGE Automated Glucose Monitoring

Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)

AqueSys Microfistula Implant in Refractory Glaucoma

Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Study of Low Level Laser Light Therapy on Circumference Reduction

Other Conditions in Chicago